Security Snapshot

RESMED INC - Common Stock (RMD) Institutional Ownership

CUSIP: 761152107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

932

Shares (Excl. Options)

96,905,413

Price

$240.87

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
RMD on NYSE
Shares outstanding
146,467,184
Price per share
$224.48
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
96,905,413
Total reported value
$23,343,200,570
% of total 13F portfolios
0.01%
Share change
+4,343,417
Value change
+$1,010,566,445
Number of holders
932
Price from insider filings
$224.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • RMD - RESMED INC - Common Stock is tracked under CUSIP 761152107.
  • 932 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 932 to 171 between Q4 2025 and Q1 2026.
  • Reported value moved from $23,343,200,570 to $324,352,687.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 932 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 761152107?
CUSIP 761152107 identifies RMD - RESMED INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 932 institutional investors reported holding 96,905,413 shares of RESMED INC - Common Stock (RMD). This represents 66% of the company’s total 146,467,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RESMED INC - Common Stock (RMD) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 18,882,403 -0.83% 0.07% $4,548,204,411
BlackRock, Inc. 8.4% 12,348,652 +0.58% 0.05% $2,974,419,664
STATE STREET CORP 4.5% 6,625,408 +1.2% 0.05% $1,595,862,025
Bank of New York Mellon Corp 3.3% 4,890,654 +7.4% 0.21% $1,178,011,765
GEODE CAPITAL MANAGEMENT, LLC 2.9% 4,302,906 +1.2% 0.06% $1,032,876,781
MORGAN STANLEY 2% 2,891,697 +25% 0.04% $696,523,345
Invesco Ltd. 1.3% 1,951,933 -7.4% 0.07% $470,162,194
NORTHERN TRUST CORP 1.2% 1,785,384 +5.2% 0.05% $430,045,444
FIRST TRUST ADVISORS LP 1% 1,517,592 +241% 0.27% $365,542,340
DEUTSCHE BANK AG\ 0.97% 1,413,477 +126% 0.11% $340,464,204
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.75% 1,103,459 +3.4% 0.04% $265,790,169
Swedbank AB 0.75% 1,102,476 +103% 0.26% $265,553,393
NORDEA INVESTMENT MANAGEMENT AB 0.74% 1,084,996 +37% 0.23% $262,026,535
NORGES BANK 0.71% 1,034,037 0.03% $249,068,492
Legal & General Group Plc 0.68% 992,527 +3.6% 0.05% $239,069,978
DIMENSIONAL FUND ADVISORS LP 0.67% 980,544 +16% 0.05% $236,202,810
GOLDMAN SACHS GROUP INC 0.67% 979,419 +14% 0.03% $235,912,822
UBS Group AG 0.62% 906,415 +3.8% 0.04% $218,328,181
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.57% 836,428 -7.8% 0.04% $201,470,413
BANK OF AMERICA CORP /DE/ 0.57% 831,024 +0.9% 0.01% $200,168,862
PRICE T ROWE ASSOCIATES INC /MD/ 0.53% 770,414 -0.23% 0.02% $185,571,000
JPMORGAN CHASE & CO 0.4% 585,608 -5.2% 0.01% $141,055,545
Tandem Investment Advisors, Inc. 0.34% 500,145 -1% 4.5% $120,469,926
Caisse de depot et placement du Quebec 0.33% 480,642 -15% 0.2% $115,772,239
CAPTRUST FINANCIAL ADVISORS 0.33% 480,058 -11% 0.22% $115,631,542

Institutional Holders of RESMED INC - Common Stock (RMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,444,249 $324,352,687 -$41,694,189 $224.48 171
2025 Q4 96,905,413 $23,343,200,570 +$1,010,566,445 $240.87 932
2025 Q3 91,805,254 $25,120,556,319 -$164,908,411 $273.73 939
2025 Q2 92,309,428 $23,802,163,537 -$234,889,533 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
2020 Q2 102,006,987 $19,585,421,181 +$701,386,093 $192.00 567
2020 Q1 98,435,082 $14,502,972,264 +$119,165,301 $147.29 574
2019 Q4 97,640,442 $15,128,001,356 +$142,829,575 $154.97 551
2019 Q3 96,630,375 $13,051,505,290 +$38,434,738 $135.11 514
2019 Q2 96,365,742 $11,754,959,118 +$23,486,040 $122.03 475
2019 Q1 97,619,409 $10,147,859,923 -$14,207,588 $103.97 468
2018 Q4 97,569,996 $11,099,337,871 +$397,513,543 $113.87 489
2018 Q3 94,081,151 $10,848,844,708 +$178,170,189 $115.34 486
2018 Q2 92,503,328 $9,581,445,253 +$226,242,346 $103.58 455
2018 Q1 90,228,934 $8,883,079,877 +$143,625,612 $98.47 435
2017 Q4 89,322,328 $7,564,180,997 +$29,233,715 $84.69 410
2017 Q3 88,883,200 $6,839,668,471 +$166,333,622 $76.96 359
2017 Q2 86,773,703 $6,755,702,862 +$42,211,359 $77.87 335
2017 Q1 86,833,338 $6,248,639,244 +$813,666,355 $71.97 368
2016 Q4 88,072,867 $5,464,641,164 -$131,915,963 $62.05 356
2016 Q3 89,994,221 $5,828,633,461 +$197,606,819 $64.79 368
2016 Q2 86,958,278 $5,499,043,282 +$226,844,283 $63.23 355
2016 Q1 83,494,592 $4,825,081,452 +$24,464,544 $57.82 365
2015 Q4 82,814,635 $4,446,599,092 +$286,786,392 $53.69 346
2015 Q3 77,270,412 $3,927,210,578 +$122,197,423 $50.96 310
2015 Q2 74,586,620 $4,203,538,985 +$12,963,111 $56.37 310
2015 Q1 73,509,048 $5,271,836,683 -$59,419,105 $71.78 323
2014 Q4 74,749,965 $4,194,016,041 +$85,626,962 $56.06 302
2014 Q3 72,751,035 $3,584,815,417 -$144,765,288 $49.27 297
2014 Q2 75,588,962 $3,827,465,671 -$207,528,760 $50.63 308
2014 Q1 80,134,321 $3,581,405,050 +$1,484,371 $44.69 314